Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live News

Aarti Drugs announced that on 17 June 2024, at around 2:30 pm IST, fire occurred at N-198 unit located at Tarapur, Maharashtra. Particular unit manufactures certain Active Pharmaceutical Ingredients (API) products for external customers. The fire was brought under control immediately, however production operation of the said unit has been temporarily disrupted. There is no loss of life or injuries reported. Adequate steps are being undertaken to restore the operation of the unit. The unit has adequate insurance coverage and intimation to Insurance Company has already been made. The Company projects no material impact on the financials and operations of business. Powered by Capital Market - Live News

Net profit of Aarti Drugs declined 15.55% to Rs 47.37 crore in the quarter ended March 2024 as against Rs 56.09 crore during the previous quarter ended March 2023. Sales declined 16.49% to Rs 619.99 crore in the quarter ended March 2024 as against Rs 742.41 crore during the previous quarter ended March 2023.For the full year,net profit rose 3.07% to Rs 171.42 crore in the year ended March 2024 as against Rs 166.31 crore during the previous year ended March 2023. Sales declined 6.90% to Rs 2528.58 crore in the year ended March 2024 as against Rs 2716.05 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales619.99742.41 -16 2528.582716.05 -7 OPM %13.8412.60 -12.5211.25 - PBDT77.7685.78 -9 286.98274.50 5 PBT64.1873.28 -12 235.53224.18 5 NP47.3756.09 -16 171.42166.31 3 Powered by Capital Market - Live News

Net profit of Aarti Drugs declined 32.03% to Rs 36.14 crore in the quarter ended March 2024 as against Rs 53.17 crore during the previous quarter ended March 2023. Sales declined 19.66% to Rs 559.53 crore in the quarter ended March 2024 as against Rs 696.41 crore during the previous quarter ended March 2023.For the full year,net profit declined 7.15% to Rs 141.88 crore in the year ended March 2024 as against Rs 152.81 crore during the previous year ended March 2023. Sales declined 9.25% to Rs 2266.91 crore in the year ended March 2024 as against Rs 2497.97 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales559.53696.41 -20 2266.912497.97 -9 OPM %12.3412.71 -11.7411.31 - PBDT62.0881.10 -23 240.15252.10 -5 PBT49.7469.42 -28 192.48204.81 -6 NP36.1453.17 -32 141.88152.81 -7 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 3 May 2024.Powered by Capital Market - Live News